0 Comment
These are the stories you should be monitoring today. The Federal Executive Council (FEC) has given approval to the National Institute for Pharmaceutical Research and Development (NAPRED) and May and Baker Plc to scale up the commercialisation and marketing of Niprisan, an anti-sickle cell drug for the treatment of sickle cell patients in Nigeria. This... Read More